Will subdued market conditions impact Concord Biotech debut?Default Banner

Will subdued market conditions impact Concord Biotech debut?

Writer
Anubhuti Mishra
Status
Online
Timer
August 18, 2023

Anubhuti Mishra, equity research analyst at Swastika Investmart also said, "The upcoming listing of Concord Biotech is expected to be at a premium of around Rs 122 (16.46 percent) per share. This would mean that the shares could list at a price of around Rs 863 per share."Read more at:

  1. Concord Biotech IPO to deliver a strong listing pop? Here's what grey market premium suggests - Business Today
  2. Will subdued market conditions impact Concord Biotech debut? - Money Control
  3. Concord Biotech IPO: Here’s what analyst says about listing - India Today
  4. Concord Biotech IPO Listing On 18 August: Check GMP, Allotment Date, Subscription Status, And Other Details - Outlook
  5. Concord Biotech IPO listing date today. GMP, experts see moderate debut - Bharat Times
No items found.
Follow us on social media:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.